Medicare Program; Request for Nominations for Members for the Medicare Evidence Development & Coverage Advisory Committee, 63554-63555 [2015-26569]

Download as PDF 63554 Federal Register / Vol. 80, No. 202 / Tuesday, October 20, 2015 / Notices number for the Public Reading Room is (202) 566–1744, and the telephone number for the ORD Docket is (202) 566–1752. Dated: October 15, 2015. Fred S. Hauchman, Director, Office of Science Policy. The Designated Federal Officer (DFO) via ´ mail at: Jace Cuje, Mail Code 8104R, Office of Science Policy, Office of Research and Development, U.S. Environmental Protection Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460; via phone/voice mail at: (202) 564–1795; or via email at: cuje.jace@epa.gov. BILLING CODE 6560–50–P FOR FURTHER INFORMATION CONTACT: The Charter of the BOSC states that the advisory committee shall provide advice and recommendations on all aspects (technical and management) of the ORD’s research program. The BOSC is federal advisory committee chartered under the Federal Advisory Committee Act (FACA), 5 U.S.C., App. 2. Additional information about the BOSC is available at: https://www2.epa.gov/ bosc. This meeting is open to the public. Any member of the public interested in receiving a draft agenda, joining the teleconference, or making a presentation during the teleconference may contact ´ Jace Cuje, DFO, via any of the contact methods listed in the FOR FURTHER INFORMATION CONTACT section above. Proposed agenda items for the meeting include, but are not limited to, the following: presentation and discussion of the subcommittee’s draft responses to the charge questions and approval of the final draft letter report prior to its submission to the BOSC Executive Committee. Written Statements: Written comments for the public teleconference must be received by noon Monday, November 2, 2015, Eastern Time, so they can be distributed to the BOSC SHC Subcommittee prior to the teleconference. Written comments ´ should be sent to Jace Cuje at the address listed in the FOR FURTHER INFORMATION CONTACT section or through regulations.gov, Docket ID No. EPA– HQ–ORD–2015–0611. Information on Services for Individuals with Disabilities: For information on access or services for individuals with disabilities, please ´ contact Jace Cuje at (202) 564–1795 or cuje.jace@epa.gov. To request accommodation of a disability, please ´ contact Jace Cuje, preferably at least ten days prior to the meeting, to give the EPA as much time as possible to process your request. mstockstill on DSK4VPTVN1PROD with NOTICES SUPPLEMENTARY INFORMATION: VerDate Sep<11>2014 17:55 Oct 19, 2015 Jkt 238001 [FR Doc. 2015–26597 Filed 10–19–15; 8:45 am] FEDERAL MEDIATION AND CONCILIATION SERVICE Labor-Management Relations Information Collection Requests Federal Mediation and Conciliation Service. ACTION: Submission for OMB Review: Request for Comments. AGENCY: The Federal Mediation and Conciliation Service (FMCS) hereby announces the submission of the following public information collection request (ICR) to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995 (Pub. L. 104–13). The information collection request is the Notice to Mediation Agencies (Agency Form F–7), OMB control number 3076–0004. No comments were received pursuant to FMCS’s prior 60-day notice in the Federal Register on August 5, 2015. This information collection request was previously approved by OMB. OMB is interested in comments on specific aspects of the collection. The OMB is particularly interested in comments that: (1) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (2) Evaluates the accuracy of the agency’s estimates of the burden of the proposed collection information; (3) Enhance the quality, utility, and clarity of the information to be collected; and (4) Minimize the burden of the collections of information on those who are to respond, including the use of appropriate automated, electronic collection technologies or other forms of information technology. Burden: FMCS receives approximately 14,400 responses to the form Notice to Mediation Agencies (OMB No. 3076–004). Affected Entities: Private sector employers and labor unions involved in interstate commerce that file notices for mediation services to the FMCS and state, local and territorial agencies. DATES: Comments must be submitted on or before November 19, 2015. SUMMARY: PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 Submit written comments to: Email: oira_submissions@ omb.eop.gov. Please include the FMCS form number, the information collection title, and the OMB control number in the subject line of the message. Comments may also be sent to fax number 202.395.5806 to the attention of Desk Officer for FMCS. SUPPLEMENTARY INFORMATION: For additional information, see the related 60-day notice published in the Federal Register at 88 FR 46581 on August 5, 2015. ADDRESSES: Dated: October 14, 2015. Jeannette Walters-Marquez, Attorney Advisor. [FR Doc. 2015–26513 Filed 10–19–15; 8:45 am] BILLING CODE 6732–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–3325–N] Medicare Program; Request for Nominations for Members for the Medicare Evidence Development & Coverage Advisory Committee Centers for Medicare & Medicaid Services, HHS. ACTION: Notice. AGENCY: This notice announces the request for nominations for membership on the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC). Among other duties, the MEDCAC provides advice and guidance to the Secretary of the Department of Health and Human Services (the Secretary) and the Administrator of the Centers for Medicare & Medicaid Services (CMS) concerning the adequacy of scientific evidence available to CMS in making coverage determinations under the Medicare program. The MEDCAC reviews and evaluates medical literature and technology assessments, and hears public testimony on the evidence available to address the impact of medical items and services on health outcomes of Medicare beneficiaries. SUMMARY: Nominations must be received by Monday, December 7, 2015. ADDRESSES: You may mail nominations for membership to the following address: Centers for Medicare & Medicaid Services, Center for Clinical Standards and Quality, Attention: Maria Ellis, 7500 Security Boulevard, Mail DATES: E:\FR\FM\20OCN1.SGM 20OCN1 Federal Register / Vol. 80, No. 202 / Tuesday, October 20, 2015 / Notices mstockstill on DSK4VPTVN1PROD with NOTICES Stop: S3–02–01, Baltimore, MD 21244 or send via email to MEDCACnomination@cms.hhs.gov. FOR FURTHER INFORMATION CONTACT: Maria Ellis, Executive Secretary for the MEDCAC, Centers for Medicare & Medicaid Services, Center for Clinical Standards and Quality, Coverage and Analysis Group, S3–02–01, 7500 Security Boulevard, Baltimore, MD 21244 or contact Ms. Ellis by phone (410–786–0309) or via email at Maria.Ellis@cms.hhs.gov. SUPPLEMENTARY INFORMATION: I. Background The Secretary signed the initial charter for the Medicare Coverage Advisory Committee (MCAC) on November 24, 1998. A notice in the Federal Register (63 FR 68780) announcing establishment of the MCAC was published on December 14, 1998. The MCAC name was updated to more accurately reflect the purpose of the committee and on January 26, 2007, the Secretary published a notice in the Federal Register (72 FR 3853), announcing that the Committee’s name changed to the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC). The current Secretary’s Charter for the MEDCAC is available on the CMS Web site at: https:// www.cms.hhs.gov/FACA/Downloads/ medcaccharter.pdf, or you may obtain a copy of the charter by submitting a request to the contact listed in the FOR FURTHER INFORMATION CONTACT section of this notice. The MEDCAC is governed by provisions of the Federal Advisory Committee Act, Public Law 92–463, as amended (5 U.S.C. App. 2), which sets forth standards for the formulation and use of advisory committees, and is authorized by section 222 of the Public Health Service Act as amended (42 U.S.C. 217A). We are requesting nominations for candidates to serve on the MEDCAC. Nominees are selected based upon their individual qualifications and not solely as representatives of professional associations or societies. We wish to ensure adequate representation of the interests of both women and men, members of all ethnic groups, and physically challenged individuals. Therefore, we encourage nominations of qualified candidates who can represent these interests. The MEDCAC consists of a pool of 100 appointed members including: 94 at-large standing members (6 of whom are patient advocates), and 6 representatives of industry interests. Members generally are recognized VerDate Sep<11>2014 17:55 Oct 19, 2015 Jkt 238001 authorities in clinical medicine including subspecialties, administrative medicine, public health, biological and physical sciences, epidemiology and biostatistics, clinical trial design, health care data management and analysis, patient advocacy, health care economics, medical ethics or other relevant professions. The MEDCAC works from an agenda provided by the Designated Federal Official. The MEDCAC reviews and evaluates medical literature and technology assessments, and hears public testimony on the evidence available to address the impact of medical items and services on health outcomes of Medicare beneficiaries. The MEDCAC may also advise the Centers for Medicare & Medicaid Services (CMS) as part of Medicare’s ‘‘coverage with evidence development’’ initiative. II. Provisions of the Notice As of June 2016, there will be 35 membership terms expiring. Of the 35 memberships expiring, 1 is an industry representative, 4 are patient advocates, and the remaining 30 membership openings are for the at-large standing MEDCAC membership. All nominations must be accompanied by curricula vitae. Nomination packages should be sent to Maria Ellis at the address listed in the ADDRESSES section of this notice. Nominees are selected based upon their individual qualifications. Nominees for membership must have expertise and experience in one or more of the following fields: • Clinical medicine including subspecialties • Administrative medicine • Public health • Biological and physical sciences • Epidemiology and biostatistics • Clinical trial design • Health care data management and analysis • Patient advocacy • Health care economics • Medical ethics • Other relevant professions We are looking particularly for experts in a number of fields. These include cancer screening, genetic testing, clinical epidemiology, psychopharmacology, screening and diagnostic testing analysis, and vascular surgery. We also need experts in biostatistics in clinical settings, dementia treatment, minority health, observational research design, stroke epidemiology, and women’s health. The nomination letter must include a statement that the nominee is willing to serve as a member of the MEDCAC and PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 63555 appears to have no conflict of interest that would preclude membership. We are requesting that all curricula vitae include the following: • Date of birth • Place of birth • Social security number • Title and current position • Professional affiliation • Home and business address • Telephone and fax numbers • Email address • List of areas of expertise In the nomination letter, we are requesting that nominees specify whether they are applying for a patient advocate position, for an at-large standing position, or as an industry representative. Potential candidates will be asked to provide detailed information concerning such matters as financial holdings, consultancies, and research grants or contracts in order to permit evaluation of possible sources of financial conflict of interest. Department policy prohibits multiple committee memberships. A federal advisory committee member may not serve on more than one committee within an agency at the same time. Members are invited to serve for overlapping 2-year terms. A member may continue to serve after the expiration of the member’s term until a successor is named. Any interested person may nominate one or more qualified persons. Self-nominations are also accepted. Individuals interested in the representative positions must include a letter of support from the organization or interest group they would represent. Dated: October 13, 2015. Patrick Conway, CMS Chief Medical Officer and Director, Center for Clinical Standards and Quality, Centers for Medicare & Medicaid Services. [FR Doc. 2015–26569 Filed 10–19–15; 8:45 am] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Statement of Organization, Functions, and Delegations of Authority Administration for Children and Families, HHS. ACTION: Notice of reorganization. AGENCY: Statement of Organization, Functions, and Delegations of Authority. The Administration for Children and Families (ACF) has reorganized. The reorganization adds SUMMARY: E:\FR\FM\20OCN1.SGM 20OCN1

Agencies

[Federal Register Volume 80, Number 202 (Tuesday, October 20, 2015)]
[Notices]
[Pages 63554-63555]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-26569]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

[CMS-3325-N]


Medicare Program; Request for Nominations for Members for the 
Medicare Evidence Development & Coverage Advisory Committee

AGENCY: Centers for Medicare & Medicaid Services, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces the request for nominations for 
membership on the Medicare Evidence Development & Coverage Advisory 
Committee (MEDCAC). Among other duties, the MEDCAC provides advice and 
guidance to the Secretary of the Department of Health and Human 
Services (the Secretary) and the Administrator of the Centers for 
Medicare & Medicaid Services (CMS) concerning the adequacy of 
scientific evidence available to CMS in making coverage determinations 
under the Medicare program.
    The MEDCAC reviews and evaluates medical literature and technology 
assessments, and hears public testimony on the evidence available to 
address the impact of medical items and services on health outcomes of 
Medicare beneficiaries.

DATES: Nominations must be received by Monday, December 7, 2015.

ADDRESSES: You may mail nominations for membership to the following 
address: Centers for Medicare & Medicaid Services, Center for Clinical 
Standards and Quality, Attention: Maria Ellis, 7500 Security Boulevard, 
Mail

[[Page 63555]]

Stop: S3-02-01, Baltimore, MD 21244 or send via email to 
MEDCACnomination@cms.hhs.gov.

FOR FURTHER INFORMATION CONTACT: Maria Ellis, Executive Secretary for 
the MEDCAC, Centers for Medicare & Medicaid Services, Center for 
Clinical Standards and Quality, Coverage and Analysis Group, S3-02-01, 
7500 Security Boulevard, Baltimore, MD 21244 or contact Ms. Ellis by 
phone (410-786-0309) or via email at Maria.Ellis@cms.hhs.gov.

SUPPLEMENTARY INFORMATION:

I. Background

    The Secretary signed the initial charter for the Medicare Coverage 
Advisory Committee (MCAC) on November 24, 1998. A notice in the Federal 
Register (63 FR 68780) announcing establishment of the MCAC was 
published on December 14, 1998. The MCAC name was updated to more 
accurately reflect the purpose of the committee and on January 26, 
2007, the Secretary published a notice in the Federal Register (72 FR 
3853), announcing that the Committee's name changed to the Medicare 
Evidence Development & Coverage Advisory Committee (MEDCAC). The 
current Secretary's Charter for the MEDCAC is available on the CMS Web 
site at: https://www.cms.hhs.gov/FACA/Downloads/medcaccharter.pdf, or 
you may obtain a copy of the charter by submitting a request to the 
contact listed in the FOR FURTHER INFORMATION CONTACT section of this 
notice.
    The MEDCAC is governed by provisions of the Federal Advisory 
Committee Act, Public Law 92-463, as amended (5 U.S.C. App. 2), which 
sets forth standards for the formulation and use of advisory 
committees, and is authorized by section 222 of the Public Health 
Service Act as amended (42 U.S.C. 217A).
    We are requesting nominations for candidates to serve on the 
MEDCAC. Nominees are selected based upon their individual 
qualifications and not solely as representatives of professional 
associations or societies. We wish to ensure adequate representation of 
the interests of both women and men, members of all ethnic groups, and 
physically challenged individuals. Therefore, we encourage nominations 
of qualified candidates who can represent these interests.
    The MEDCAC consists of a pool of 100 appointed members including: 
94 at-large standing members (6 of whom are patient advocates), and 6 
representatives of industry interests. Members generally are recognized 
authorities in clinical medicine including subspecialties, 
administrative medicine, public health, biological and physical 
sciences, epidemiology and biostatistics, clinical trial design, health 
care data management and analysis, patient advocacy, health care 
economics, medical ethics or other relevant professions.
    The MEDCAC works from an agenda provided by the Designated Federal 
Official. The MEDCAC reviews and evaluates medical literature and 
technology assessments, and hears public testimony on the evidence 
available to address the impact of medical items and services on health 
outcomes of Medicare beneficiaries. The MEDCAC may also advise the 
Centers for Medicare & Medicaid Services (CMS) as part of Medicare's 
``coverage with evidence development'' initiative.

II. Provisions of the Notice

    As of June 2016, there will be 35 membership terms expiring. Of the 
35 memberships expiring, 1 is an industry representative, 4 are patient 
advocates, and the remaining 30 membership openings are for the at-
large standing MEDCAC membership.
    All nominations must be accompanied by curricula vitae. Nomination 
packages should be sent to Maria Ellis at the address listed in the 
ADDRESSES section of this notice. Nominees are selected based upon 
their individual qualifications. Nominees for membership must have 
expertise and experience in one or more of the following fields:

 Clinical medicine including subspecialties
 Administrative medicine
 Public health
 Biological and physical sciences
 Epidemiology and biostatistics
 Clinical trial design
 Health care data management and analysis
 Patient advocacy
 Health care economics
 Medical ethics
 Other relevant professions

    We are looking particularly for experts in a number of fields. 
These include cancer screening, genetic testing, clinical epidemiology, 
psychopharmacology, screening and diagnostic testing analysis, and 
vascular surgery. We also need experts in biostatistics in clinical 
settings, dementia treatment, minority health, observational research 
design, stroke epidemiology, and women's health.
    The nomination letter must include a statement that the nominee is 
willing to serve as a member of the MEDCAC and appears to have no 
conflict of interest that would preclude membership. We are requesting 
that all curricula vitae include the following:

 Date of birth
 Place of birth
 Social security number
 Title and current position
 Professional affiliation
 Home and business address
 Telephone and fax numbers
 Email address
 List of areas of expertise

    In the nomination letter, we are requesting that nominees specify 
whether they are applying for a patient advocate position, for an at-
large standing position, or as an industry representative. Potential 
candidates will be asked to provide detailed information concerning 
such matters as financial holdings, consultancies, and research grants 
or contracts in order to permit evaluation of possible sources of 
financial conflict of interest. Department policy prohibits multiple 
committee memberships. A federal advisory committee member may not 
serve on more than one committee within an agency at the same time.
    Members are invited to serve for overlapping 2-year terms. A member 
may continue to serve after the expiration of the member's term until a 
successor is named. Any interested person may nominate one or more 
qualified persons. Self-nominations are also accepted. Individuals 
interested in the representative positions must include a letter of 
support from the organization or interest group they would represent.

    Dated: October 13, 2015.
Patrick Conway,
CMS Chief Medical Officer and Director, Center for Clinical Standards 
and Quality, Centers for Medicare & Medicaid Services.
[FR Doc. 2015-26569 Filed 10-19-15; 8:45 am]
 BILLING CODE 4120-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.